Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Mise à jour : Il y a 4 ans
Référence : NCT00409682

Femme et Homme

Extrait

The purpose of this study is to determine Efficacy, Pharmacokinetics, and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease


Critère d'inclusion

  • Crohn’s Disease


Liens